相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR+/HER2- Breast Cancer
Sarah Sammons et al.
CLINICAL BREAST CANCER (2020)
Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy
Bo-Duan Xiao et al.
WORLD JOURNAL OF STEM CELLS (2020)
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives
Giuseppe Badalamenti et al.
RADIOLOGIA MEDICA (2019)
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
Nicholas C. Turner et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Allosteric Regulation of Cyclin-B Binding by the Charge State of Catalytic Lysine in CDK1 Is Essential for Cell-Cycle Progression
Shaunak Deota et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
Andrew L. Hong et al.
ELIFE (2019)
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
Florian Handle et al.
SCIENTIFIC REPORTS (2019)
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
H. S. Rugo et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
Sherri Z. Millis et al.
CANCER (2019)
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li et al.
CLINICAL CANCER RESEARCH (2019)
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The broken cycle: E2F dysfunction in cancer
Lindsey N. Kent et al.
NATURE REVIEWS CANCER (2019)
TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer
Alexandra M. Blee et al.
CLINICAL CANCER RESEARCH (2018)
Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1) eDeficient Carcinomas of the Urinary System
Sumati Gupta et al.
CLINICAL GENITOURINARY CANCER (2018)
Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies
Dorota Kwapisz
BREAST CANCER (2018)
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
Ben O'Leary et al.
CANCER DISCOVERY (2018)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
Jiayuan Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration
Julia A. Elvin et al.
ONCOLOGIST (2017)
Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability
Cheyennedra C. Bieg-Bourne et al.
CANCER RESEARCH (2017)
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Myrella Vlenterie et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
Julien Calderaro et al.
EUROPEAN UROLOGY (2016)
Gene of the month: SMARCB1
Sangeetha N. Kalimuthu et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics
Teresa Helsten et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
Ran Zhao et al.
EBIOMEDICINE (2016)
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
Shumei Kato et al.
CELL CYCLE (2015)
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
Maria Schwaederle et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Cyclin alterations in diverse cancers: outcome and co-amplification network
Maria Schwaederle et al.
ONCOTARGET (2015)
Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
Qin Li et al.
CLINICAL CANCER RESEARCH (2013)
RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
Riccardo Di Fiore et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
The SWI/SNF complex - Chromatin and cancer
CWM Roberts et al.
NATURE REVIEWS CANCER (2004)
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
RI Skotheim et al.
NEOPLASIA (2003)
分享论文
